type 6 Amyotrophic lateral sclerosis

mutation in FUS gene

Also Known As:

Amyotrophic lateral sclerosis, type 6; Amyotrophic Lateral Sclerosis 6

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Frontotemporal Dementia (Semantic Dementia)
2.	Neurodegenerative Diseases (Neurodegenerative Disease)
3.	Sarcoma (Soft Tissue Sarcoma)
4.	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

Drugs and Important Biological Agents (IBA) related to type 6 Amyotrophic lateral sclerosis:

1.	Proteins (Proteins, Gene)FDA Link 02/27/2009 - "Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6." 01/01/2021 - "Molecular dynamics and protein frustration analysis of human fused in Sarcoma protein variants in Amyotrophic Lateral Sclerosis type 6: An In Silico approach."
2.	Protease Inhibitors (Protease Inhibitor)IBA 02/01/1989 - "Serum levels of 4 protease inhibitors, alpha-1-antitrypsin, C1-inactivator, alpha-2-macroglobulin and antithrombin-III were measured in 11 patients with amyotrophic lateral sclerosis (6 males and 5 females) and a control group without neurologic disease. "
3.	Antithrombin IIIIBA 02/01/1989 - "Serum levels of 4 protease inhibitors, alpha-1-antitrypsin, C1-inactivator, alpha-2-macroglobulin and antithrombin-III were measured in 11 patients with amyotrophic lateral sclerosis (6 males and 5 females) and a control group without neurologic disease. "
4.	Valosin Containing ProteinIBA 01/01/2023 - "Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, also known as amyotrophic lateral sclerosis 14, is an autosomal dominant, progressive neurodegenerative disorder caused by various mutations in the valosin-containing protein gene. "